Alexandra General Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Amyloidosis1 trial
• Childhood cancers1 trial
• Endometrial cancer1 trial
• Heart failure1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials

Status

• Recruiting4 trials
• Completed2 trials

Lead sponsor

• Argyrios Ntalianis1 trial
• CareAcross1 trial
• Genmab1 trial
• Hellenic Cooperative Oncology Group1 trial
• Ionis Pharmaceuticals, Inc.1 trial
• and 1 more

Running trials

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· Phase 3· Genmab· Source

• Recruiting

  Digital Support for Multiple Myeloma Quality of Life

  NCT07642362· CareAcross· Source

  Contact: Professor Evangelos Terpos

• Recruiting

  Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

  NCT05879757· Takeda· Source

  Contact: Efstathios Kastritis (principal investigator)

• Recruiting

  Analysis of Whole Exome and Transcriptome Sequencing to Identify Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC)

  NCT07900581· Hellenic Cooperative Oncology Group· Source

  Contact: Flora Zagouri

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma2 recruiting
• Childhood cancers1 recruiting
• Endometrial cancer1 recruiting
• Lung cancer1 recruiting

Closed trials

• Completed

  Vericiguat and Exercise Hemodynamics in Patients With HFrEF

  NCT07697365· Argyrios Ntalianis· Source

• Completed

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· Phase 3· Ionis Pharmaceuticals, Inc.· Source